Immunohistochemical localization of group I and II metabotropic glutamate receptors in control and amyotrophic lateral sclerosis human spinal cord: upregulation in reactive astrocytes
- PMID: 11672616
- DOI: 10.1016/s0306-4522(01)00181-6
Immunohistochemical localization of group I and II metabotropic glutamate receptors in control and amyotrophic lateral sclerosis human spinal cord: upregulation in reactive astrocytes
Abstract
Excitotoxicity, which is mediated by the excessive activation of glutamate receptors, has been implicated in the pathogenesis of amyotrophic lateral sclerosis (ALS). There is substantial information about the distribution and function of ionotropic glutamate receptors in the spinal cord, although the role of metabotropic glutamate receptors (mGluRs) is poorly understood in this region of the brain, particularly under pathological conditions. We used immunocytochemistry to study the general distribution of group I and group II mGluR immunoreactivity in the human spinal cord, as well as the cell-specific expression of these receptors. We also investigated whether mGluR expression was altered in the spinal cord of patients with sporadic and familial ALS. Immunocytochemical analysis of control human spinal cord demonstrated that mGluR1alpha and mGluR5 (group I mGluRs) were highly represented in neuronal cells throughout the spinal cord. mGluR1alpha showed the highest relative level of expression in ventral horn neurons (laminae VIII and IX), whereas intense mGluR5 immunoreactivity was observed within the dorsal horn (superficial laminae I and II). Group II mGluRs (mGluR2/3) immunoreactivity was mainly concentrated in the inner part of the lamina II. With respect to specific neuronal populations, mGluR2/3 and mGluR5 appeared to be most frequently expressed in calbindin-containing and calretinin-containing cells, respectively. In control spinal cord only sparse astrocytes showed a weak to moderate mGluR immunoreactivity. Regional differences in immunoreactivity were apparent in ALS compared to control. In particular, mGluR expression was increased in reactive glial cells in both gray (ventral horn) and white matter of ALS spinal cord. Upregulation of mGluRs in reactive astrocytes may represent a critical mechanism for modulation of glial function and changes in glial-neuronal communication in the course of neurodegenerative diseases.
Similar articles
-
Expression and cell distribution of group I and group II metabotropic glutamate receptor subtypes in taylor-type focal cortical dysplasia.Epilepsia. 2003 Jun;44(6):785-95. doi: 10.1046/j.1528-1157.2003.54802.x. Epilepsia. 2003. PMID: 12790891
-
In-vivo effects of knocking-down metabotropic glutamate receptor 5 in the SOD1G93A mouse model of amyotrophic lateral sclerosis.Neuropharmacology. 2017 Sep 1;123:433-445. doi: 10.1016/j.neuropharm.2017.06.020. Epub 2017 Jun 21. Neuropharmacology. 2017. PMID: 28645622
-
Knocking down metabotropic glutamate receptor 1 improves survival and disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.Neurobiol Dis. 2014 Apr;64:48-59. doi: 10.1016/j.nbd.2013.11.006. Epub 2013 Dec 19. Neurobiol Dis. 2014. PMID: 24361555
-
Reactive Astrocytes as Therapeutic Targets for Brain Degenerative Diseases: Roles Played by Metabotropic Glutamate Receptors.Neurochem Res. 2020 Mar;45(3):541-550. doi: 10.1007/s11064-020-02968-6. Epub 2020 Jan 25. Neurochem Res. 2020. PMID: 31983009 Free PMC article. Review.
-
The Physio-Pathological Role of Group I Metabotropic Glutamate Receptors Expressed by Microglia in Health and Disease with a Focus on Amyotrophic Lateral Sclerosis.Int J Mol Sci. 2023 Mar 9;24(6):5240. doi: 10.3390/ijms24065240. Int J Mol Sci. 2023. PMID: 36982315 Free PMC article. Review.
Cited by
-
mGluR5 protect astrocytes from ischemic damage in postnatal CNS white matter.Cell Calcium. 2015 Nov;58(5):423-30. doi: 10.1016/j.ceca.2015.06.010. Epub 2015 Jun 30. Cell Calcium. 2015. PMID: 26189008 Free PMC article.
-
Blocking glutamate mGlu5 receptors with the negative allosteric modulator CTEP improves disease course in SOD1G93A mouse model of amyotrophic lateral sclerosis.Br J Pharmacol. 2021 Sep;178(18):3747-3764. doi: 10.1111/bph.15515. Epub 2021 Jun 29. Br J Pharmacol. 2021. PMID: 33931856 Free PMC article.
-
Metabotropic glutamate receptor-mediated signaling in neuroglia.Wiley Interdiscip Rev Membr Transp Signal. 2012 Mar;1(2):136-150. doi: 10.1002/wmts.30. Epub 2012 Jan 11. Wiley Interdiscip Rev Membr Transp Signal. 2012. PMID: 22662309 Free PMC article.
-
Therapeutic promise and principles: metabotropic glutamate receptors.Oxid Med Cell Longev. 2008 Oct-Dec;1(1):1-14. doi: 10.4161/oxim.1.1.6842. Oxid Med Cell Longev. 2008. PMID: 19750024 Free PMC article. Review.
-
mGluR5 from Primary Sensory Neurons Promotes Opioid-Induced Hyperalgesia and Tolerance by Interacting with and Potentiating Synaptic NMDA Receptors.J Neurosci. 2023 Aug 2;43(31):5593-5607. doi: 10.1523/JNEUROSCI.0601-23.2023. Epub 2023 Jul 14. J Neurosci. 2023. PMID: 37451981 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous